| Type 1 Diabetes Mellitus |
1 |
1 |
| Preventive Screening |
0 |
0.82 |
| Pregnancy |
0 |
0.67 |
| Genomic Medicine |
0 |
0.52 |
| Obesity |
0 |
0.41 |
| Type 2 Diabetes Mellitus |
0 |
0.99 |
| Blood |
0 |
0.31 |
| Biliary Disease |
0 |
0.25 |
| Renal Disease |
0 |
0.22 |
| Chronic Kidney Disease |
0 |
0.21 |
| Renal Failure |
0 |
0.21 |
| Hypertension |
0 |
0.2 |
| Kidney |
0 |
0.2 |
| Metabolic Syndrome |
0 |
0.2 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.2 |
| COVID-19 |
0 |
0.17 |
| Social Determinants of Health |
0 |
0.16 |
| Fatty Liver |
0 |
0.14 |
| Foot Care |
0 |
0.14 |
| Genetic Testing |
0 |
0.14 |
| Liver Disease |
0 |
0.14 |
| Cardiovascular disease |
0 |
0.1 |
| Disease Management |
0 |
0.1 |
| Genetics |
0 |
0.1 |
| Gestational Diabetes Mellitus |
0 |
0.1 |
| Health Care Inequities |
0 |
0.1 |
| Health Equity |
0 |
0.1 |
| Hypoglycemia |
0 |
0.1 |
| Liver |
0 |
0.1 |
| Neuropathy |
0 |
0.1 |
| Pandemic |
0 |
0.1 |
| Pedal |
0 |
0.1 |
| Prediabetes |
0 |
0.1 |
| Retinopathy |
0 |
0.1 |
| Risk Management |
0 |
0.1 |
| Cardiovascular Risk Management |
0 |
0.08 |
| Lipids Management |
0 |
0.08 |
| Retinal Diseases |
0 |
0.08 |
| Weight Management |
0 |
0.08 |